Real-world attrition rates after second-line therapy or later in patients from the flatiron database with relapsed/refractory multiple myeloma refractory to lenalidomide
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)
Key words
relapsed/refractory multiple myeloma relapsed/refractory,multiple myeloma,lenalidomide,second-line second-line therapy,attrition rates,real-world
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined